Code	Sector	Market
4894	Pharmaceuticals	Growth

Date of listing approval	2023/05/23
Expected Date	2023/06/27
Lead Underwriter	Nomura
Description

Listed Shares(total)	2,530,000
Trading Unit	100
New Shares	1,700,000
Existing Shares	830,000（incl. O.A.）
Shares Outstanding	PreIPO 5,857,916.00
	PostIPO 7,557,916.00
Paid Up Capital	PreIPO Y104,150,000
	PostIPO Y909,656,000
Expected Pricing Date	2023/06/08
Book Building Start	2023/06/09
Book Building End	2023/06/15
Fix Date	2023/06/16
Offering Starts	2023/06/19
Offering Ends	2023/06/22
Expect Pricing	Y1,400-Y1,560
Notional PER (based on previous period)	-21.02--23.42
Notional PER(based on results forecast)	-8.02--8.94
Offering Price	Y1,560
Offering Price PER (based on previous period)	-8.02--8.94
Offering Price PBR (based on previous period)	2.27
Offering Price PER (based on results forecast)	-8.94
Use of Funds Raised

Units:Y1,000

Fiscal Year End:2020/03
	Consolidated	Non-consolidated
Revenue	-
Current Profit	-	-176,987
Net Profit	-	-179,833
Net Assets	-	750,177

Fiscal Year End:2021/03
	Consolidated	Non-consolidated
Revenue	-	220
Current Profit	-	-295,845
Net Profit	-	-307,834
Net Assets	-	4,222,342

Fiscal Year End:2022/03
	Consolidated	Non-consolidated
Revenue	-	13,913
Current Profit	-	-373,140
Net Profit	-	-375,337
Net Assets	-	3,895,546

Recent Quarter 2022/12
	Consolidated	Non-consolidated
Revenue	-	13,488
Current Profit	-	-356,243
Net Profit	-	-357,352
Net Assets	-	3,548,348

Results Forecast 2024/03
	Consolidated	Non-consolidated
Revenue	-	215,000
Current Profit	-	-1,246,000
Net Profit	-	-1,249,000
Net Assets	-	-

Per Share Units:Y1

Fiscal Year End:2020/03
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-97.31	407.24

Fiscal Year End:2021/03
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-123.65	751.03

Fiscal Year End:2022/03
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-66.60	686.19

Fiscal Year End:Recent Quarter 2022/12
	Consolidated	Non-consolidated
Dividend
Net Earning	-	-63.16
Equity	-	-

Fiscal Year End:Results Forecast 2024/03
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-174.50
Equity	-	-

■Over allotment(330,000)

Name	Address

Allocation	Underwriter	Tel
0%	Nomura	03-3211-1811
92%	Nomura	03-3211-1811
7.5%	SBI SECURITIES Co.,Ltd.	03-5562-7210
0.5%	Matsui	03-5216-0606